Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading uranium producer in the United States, is strategically positioned to capitalize on the Trump administration’s recently announced plan to revitalize the U.S. nuclear energy industry (http://ibn.fm/mvTrl).…
POAI boasts unique historical database documenting actual drug responses of tumors – the largest in the world with over 150,000 tumors across 137 types Drug discovery funding for subsidiary Helomics planned through relationships with large…
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announced…
Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the additive manufacturing industry, today announced that it will present at the Virtual Investor Summit, slated to take place June 9-12, 2020. Sigma…
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Wednesday released its audited consolidated financial statements for the fiscal year ended March 31, 2020 (“FY 2020”) and management’s discussion and…
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced that management will present at the June 2020 Virtual Investor Summit slated to take place June 9-12, 2020. According to the…
Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) and certain of its direct and indirect wholly owned subsidiaries (collectively “GGB”, the “company” or the “Applicants”) on Tuesday released an update on its insolvency proceedings under the…
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, on Tuesday announced the completion of the acquisitions of two wholly owned subsidiaries of InventaBioTech, Inc.,…
POAI addresses pressing need for a multi-omic approach in field of precision medicine Global precision medicine market is expected to reach total market value of approximately $84 billion by 2026 Predictive Oncology’s ‘claim to fame’ is…
Predictive Oncology (NASDAQ: POAI), through its Helomics subsidiary, is leveraging its proprietary database of more than 150,000 tumor genomic and drug response profiles to improve cancer outcomes. An article discussing the company reads, “With a…
Trxade Group (NASDAQ: MEDS), through its virtual healthcare subsidiary Bonum Health, provides telehealth services and prescription ordering via teleconferences that are conducted using smart devices. A recent article discussing the company reads, “The service provides…
COVID-19 exposed weaknesses in manufacturing, supply chain spaces; 3D printing offers ideal solution 3D-metal-printing presents its own mechanical hurdles, including quality issues undetected until postproduction SGLB’s patented PrintRite3D(R) software provides solution to costly quality-control challenges…